Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome.

AIMS Influenza infection has been shown to accentuate the progression of atherosclerosis and precipitate the occurrence of acute coronary syndrome (ACS). However, the protective effects of the influenza vaccine on cardiovascular events are still inconclusive. METHODS AND RESULTS The study was a prospective randomized open with blinded endpoint (PROBE) study. The 439 patients who had been admitted due to ACS within 8 weeks were enrolled and randomly allocated to receive inactivated influenza vaccine in the vaccine group and no treatment in the control group. All patients were treated with the standard therapy including revascularization according to primary cardiologists. The primary endpoint, which was the combined major cardiovascular events, including death, hospitalization from ACS, hospitalization from heart failure, and hospitalization from stroke, occurred less frequently in the vaccine group than the control group [9.5 vs. 19.3%, unadjusted HR 0.70 (0.57-0.86), P = 0.004]. There was no significant difference in the incidence of cardiovascular death between the vaccine and control groups [2.3 vs. 5.5%, unadjusted HR 0.39 (0.14-1.12), P = 0.088]. CONCLUSION The influenza vaccine reduced major cardiovascular events in patients with ACS. Therefore, it should be encouraged as a secondary prevention in this group of patients.

[1]  J. Aguado,et al.  Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital , 2010, Vaccine.

[2]  Atlanta,et al.  Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010. , 2010, MMWR. Morbidity and mortality weekly report.

[3]  S. Razavi,et al.  Antibody response to influenza immunization in coronary artery disease patients: a controlled trial. , 2009, Vaccine.

[4]  Liam Smeeth,et al.  Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. , 2009, The Lancet. Infectious diseases.

[5]  S. Sarna,et al.  Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes , 2009, Therapeutic advances in cardiovascular disease.

[6]  J. Hayashi,et al.  Association of Chlamydophila pneumoniae DNA in peripheral blood mononuclear cells and IgA antibody with atherosclerotic diseases. , 2009, Fukuoka igaku zasshi = Hukuoka acta medica.

[7]  F. Hayden,et al.  Influenza vaccination of health care workers in hospitals--a review of studies on attitudes and predictors. , 2009, Vaccine.

[8]  M. Nieminen,et al.  Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum , 2009, Scandinavian journal of infectious diseases.

[9]  A. Sukonthasarn,et al.  Evidence of influenza or influenza-like-illness preceding acute coronary syndrome. , 2008, The Southeast Asian journal of tropical medicine and public health.

[10]  Li-xin Jiang,et al.  Influenza Virus Infection and Risk of Acute Myocardial Infarction , 2008, Inflammation.

[11]  C. Kȩpka,et al.  Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. , 2008, European heart journal.

[12]  R. Harskamp,et al.  Acute respiratory tract infections: A potential trigger for the acute coronary syndrome , 2008, Annals of medicine.

[13]  Pesus Chou,et al.  Impact of influenza vaccination on major cause-specific mortality. , 2007, Vaccine.

[14]  T. van der Poll,et al.  Effects on Coagulation and Fibrinolysis Induced by Influenza in Mice With a Reduced Capacity to Generate Activated Protein C and a Deficiency in Plasminogen Activator Inhibitor Type 1 , 2006, Circulation research.

[15]  Ildikó Kriszbacher,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, New England Journal of Medicine.

[16]  Imran Awan,et al.  Influenza and atherosclerosis: vaccination for cardiovascular disease prevention , 2005, Expert opinion on biological therapy.

[17]  E. Gurfinkel,et al.  Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. , 2004, European heart journal.

[18]  R. Poledne,et al.  Influenza--a trigger for acute myocardial infarction. , 2004, Atherosclerosis.

[19]  Imran Awan,et al.  Influenza and cardiovascular disease: is there a causal relationship? , 2004, Texas Heart Institute journal.

[20]  M. Naghavi,et al.  Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. , 2003, Circulation.

[21]  S. Schneider,et al.  Antibiotic Therapy After Acute Myocardial Infarction: A Prospective Randomized Study , 2003, Circulation.

[22]  M. Naghavi,et al.  Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E–Deficient Mice , 2003, Circulation.

[23]  A. Kastrati,et al.  Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial. , 2001, Lancet.

[24]  M. Naghavi,et al.  Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction , 2000, Circulation.

[25]  T. Raghunathan,et al.  Influenza vaccination and the risk of primary cardiac arrest. , 2000, American journal of epidemiology.

[26]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[27]  D. Porter,et al.  Respiratory Viral Antigens in Autopsy Lung Tissue Specimens from Patients with Cancer or Myocardial Infarction , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[29]  M. Stenvik,et al.  Viral and mycoplasmal antibodies in patients with myocardial infarction. , 1981, Annals of clinical research.